Sutro Biopharma reports Q3 2026 results, advances ADC pipeline and Astellas collaborationNov 12Quarterly updateAstellas PharmaSTRO-004
UIC registers Phase 1 trial of Pfizer's elranatamab in plasmablastic lymphomaOct 30Weekly roundup, 11 itemsAstellas Pharmaatirmociclib
Vir Biotechnology says FDA grants Fast Track to VIR-5500 for prostate cancerOct 8Regulatory milestoneAstellas PharmaVir Biotechnology, Inc.
Astellas registers Phase 1/2 gene therapy trial for ASP2767 in glaucoma optic nerve damageAug 19Weekly roundup, 2 itemsASP2767Astellas Pharma